Hot Stocks: Brokerage view on HDFC Bank, Apollo Hospitals & Zomato; BofA upgraded M&M
Brokerage firm Macquarie maintained an underperform rating on Zomato and Apollo Hospitals. BofA Securities recommended a buy on HDFC Bank and upgraded M&M to a buy.
We have collated a list of from top brokerage firms from ETNow and other sources:on : Underperform| Target Rs 96
Macquarie maintained an underperform rating on Zomato with a target price of Rs 96. The competitive intensity is rising.
Multiple incumbent e-commerce platforms have announced renewed ambitions in Qcom. The global investment bank considers Blinkit as an efficient operator.
Despite the large potential TAM of India retail, with rising competitive intensity, continue to see downside to consensus estimates.
Macquarie on : Underperform| Target Rs 4,200
Macquarie maintained an underperform rating on Apollo Hospitals with a target price of Rs 4200. Q4 results were operationally in line with estimates but hospital profitability declined.
Higher depreciation and amortisation expenses led to PAT miss. Hospital business EBITDA margin compressed 130 bps YoY and 70 bps QoQ to 23.1%.
on : Buy| Target Rs 1,800
Securities maintained a buy rating on HDFC Bank with a target price of Rs 1800. The private sector lender seems to have bottomed out and re-rating is possible.
In FY25, the EPS cut cycle bottomed out. The global investment bank believes that the current EPS expectations are low enough and we might finally see an end to the EPS downgrade cycle.
BofA Securities on M&M: Buy| Target Rs 3050
BofA Securities upgraded M&M to a buy from neutral earlier and raised the target price to Rs 3050 from Rs 2480 earlier.
on : Buy| Target Rs 13010
Antique initiated a buy rating on PTC Industries with a target price of Rs 13,010. •
All that glitters is Titanium. It is a closely guarded manufacturing technology and high margins.
Casting a highly value additive segment. Titanium-at the heart of aerospace manufacturing.
The geopolitical situation is extremely favorable to PTC. Agreements provide long-term order book visibility.
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
Despite the large potential TAM of India retail, with rising competitive intensity, continue to see downside to consensus estimates.
Macquarie on : Underperform| Target Rs 4,200
Macquarie maintained an underperform rating on Apollo Hospitals with a target price of Rs 4200. Q4 results were operationally in line with estimates but hospital profitability declined.
Higher depreciation and amortisation expenses led to PAT miss. Hospital business EBITDA margin compressed 130 bps YoY and 70 bps QoQ to 23.1%.
on : Buy| Target Rs 1,800
Securities maintained a buy rating on HDFC Bank with a target price of Rs 1800. The private sector lender seems to have bottomed out and re-rating is possible.
In FY25, the EPS cut cycle bottomed out. The global investment bank believes that the current EPS expectations are low enough and we might finally see an end to the EPS downgrade cycle.
BofA Securities on M&M: Buy| Target Rs 3050
BofA Securities upgraded M&M to a buy from neutral earlier and raised the target price to Rs 3050 from Rs 2480 earlier.
on : Buy| Target Rs 13010
Antique initiated a buy rating on PTC Industries with a target price of Rs 13,010. •
All that glitters is Titanium. It is a closely guarded manufacturing technology and high margins.
Casting a highly value additive segment. Titanium-at the heart of aerospace manufacturing.
The geopolitical situation is extremely favorable to PTC. Agreements provide long-term order book visibility.
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
Source: Stocks-Markets-Economic Times
